Site Search

Entire (RSS)
Comments (RSS)

Archive Calendar

September 2021


How to Become a Bounty Hunter

Archive for September 29th, 2021

Chipman, Biden’s Failed ATF Nominee, Says White House Abandoned Him

Former ATF Agent David Chipman, via Twitter.

By Steve Neavling

President Biden’s pick to lead the ATF, David Chipman, said the White House abandoned him as his nomination floundered in the Senate. 

In his first interview since Biden withdrew the nomination, Chipman told The New York Times that he had no contact with the White House, leaving him feeling like he was on “an island.”

Chipman, 55, said the Biden administration’s sole focus was on convincing Sen. Joe Manchin III, a centrist Democrat from West Virginia, to support his nomination. In the end, Sen. Angus King, an independent from Maine, refused to become the final vote needed for confirmation. 

“Either this was impossible to win, or the strategy failed,” Chipman said. “This was a failure.”

Chipman, a gun owner and former ATF agent, came under fire for his support of firearm restrictions, including a ban on assault weapons. He’s also a former adviser at the Giffords, a gun control group. 

The National Rifle Association and National Shooting Sports Foundation put up an aggressive fight to stop Chipman’s nomination and spent more than $4 million in radio and TV ads in the home states of moderate Democrats and King.

Chipman’s nomination advanced from the Senate Judiciary Committee after a 10-10 vote in June. But since then, Democrats had not scheduled a confirmation vote because they weren’t sure if Chipman had enough support. 

Chipman said he was surprised the White House didn’t speak with him during the process. 

“In the back of my mind, I always thought that there would be a Plan B, but so far there hasn’t been,” Chipman said. 

In early September, Chipman finally heard from the White House. Presidential adviser Steve Ricchetti called Chipman to express regret that the nomination didn’t have enough support. 

DEA Issues First Public Safety Alert in Six Years As Counterfeit Pills Flood the Market

By Steve Neavling

The DEA on Tuesday issued a rare warning about mass-produced counterfeit pills containing lethal doses of fentanyl that have been linked to fatalities. 

The public safety alert was the agency’s first in six years. 

According to the alert, more than 9.5 million counterfeit pills have been seized so far this year, which is more than the last two years combined. 

Lab testing found that the pills contain at least two milligrams of fentanyl, which is considered a lethal dose. 

Criminal drug networks are manufacturing the pills, which look like real prescription medications such as oxycodone, hydocodone, alprazolam, and amphetamines such as Adderall. 

“Across our five state Division, we’ve seen a staggering influx in counterfeit pills,” DEA Omaha Division Special Agent in Charge Justin C. King said in a news release. “This is not an East Coast or West Coast problem, but one that the entire nation is facing. We’re seeing these pills in our own Midwestern communities. By raising awareness to this alarming trend, we’re hopeful that we can save families the heartache of losing a loved one. Every life is precious and we want to prevent as many people as possible from making a choice that has permanent repercussions.”

Most of the counterfeit pills are produced in Mexico and brought to the U.S. 

More than 93,000 people died of a drug overdose in the U.S. last year, and the “primary driver of this alarming increase” is fentanyl, the DEA said.